Grand Rounds Series: Part 8 — Urothelial Bladder Carcinoma (Webinar Audio Proceedings)

Submitted by web@researchtop... on Wed, 09/02/2020 - 09:51

Listen to streaming audioright from your computer
Download programto your desktop
Subscribe to podcastto have this and future issues delivered to your iTunes library

Audio Highlights

Topic 1:	Introduction
Topic 2:	Overview of Urothelial Bladder Cancer (UBC) Management
Topic 3:	Anti-PD-1/PD-L1 Antibodies for Patients with Nonmetastatic UBC
Topic 4:	Risks and Benefits of Immune Checkpoint Inhibitors in Advanced UBC
Topic 5:	Integration of FGFR-Directed Therapy into Current UBC Management Algorithms
Topic 6:	Antibody-Drug Conjugates in UBC
Topic 7:	Management of UBC in the Era of COVID-19

FACULTY

Arjun Balar, MD
Associate Professor
Department of Medicine
Director
Genitourinary Medical Oncology Program
NYU Perlmutter Cancer Center
New York, New York

Anastassia Daskalova, NP
Genitourinary Medical Oncology
Mount Sinai Hospital
New York, New York

Peter H O’Donnell, MD
Associate Professor
Department of Medicine
Section of Hematology/Oncology
Genitourinary Oncology Program
The University of Chicago
Chicago, Illinois

Susan K Roethke, CRNP, MSN, ANP-BC, AOCNP
Genitourinary Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

MODERATOR

Neil Love, MD
Research To Practice
Miami, Florida